Frede Donskov
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- Renal cell carcinoma treatment 182
- Oncology 68
- Cancer Immunotherapy and Biomarkers 36
- Pancreatic and Hepatic Oncology Research 13
- Cancer Diagnosis and Treatment 10
- Co-authors
- Hans von der Maase (16 shared papers)Toni K. Choueiri (117 shared papers)Brian I. Rini (77 shared papers)Georg A. Bjarnason (71 shared papers)Lori Wood (66 shared papers)Daniel Y.C. Heng (40 shared papers)Christian Kollmannsberger (55 shared papers)Ulka N. Vaishampayan (43 shared papers)
- Journals
- Journal of Clinical Oncology (89 papers)Annals of Oncology (22 papers)Clinical Genitourinary Cancer (15 papers)European Urology (14 papers)European Journal of Cancer (10 papers)
- Partner nations
- DenmarkUnited StatesCanada
In The Last Decade
Frede Donskov
229 papers receiving 8.5k citations
Frede Donskov's Hit Papers
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 5.1k
- Oncology 3.0k
- Cancer Research 1.5k
- Immunology 1.3k
- Molecular Biology 2.0k
Countries citing papers authored by Frede Donskov
This map shows the geographic impact of Frede Donskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frede Donskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frede Donskov more than expected).
Fields of papers citing papers by Frede Donskov
This network shows the impact of papers produced by Frede Donskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frede Donskov. The network helps show where Frede Donskov may publish in the future.
Co-authors
The 25 scholars most cited alongside Frede Donskov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Hit paper breakdown → | 2013 | 756 |
| 2 | 2009 | 384 | |
| 3 | Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial Hit paper breakdown → | 2020 | 359 |
| 4 | Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Hit paper breakdown → | 2014 | 322 |
| 5 | The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study Hit paper breakdown → | 2015 | 292 |
| 6 | 2014 | 277 | |
| 7 | 2006 | 262 | |
| 8 | 2013 | 242 | |
| 9 | 2011 | 223 | |
| 10 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2021 | 188 |
| 11 | 2013 | 188 | |
| 12 | 2017 | 187 | |
| 13 | 2017 | 178 | |
| 14 | Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival Hit paper breakdown → | 2021 | 175 |
| 15 | 2013 | 174 | |
| 16 | 2018 | 155 | |
| 17 | 2016 | 127 | |
| 18 | 2013 | 115 | |
| 19 | 2011 | 113 | |
| 20 | 2021 | 111 |
About Frede Donskov
Frede Donskov is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Economics and Econometrics, having authored 239 papers that have together received 8.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (182 papers), Cancer Genomics and Diagnostics (57 papers), Renal and related cancers (42 papers), Cancer Immunotherapy and Biomarkers (36 papers), Economic and Financial Impacts of Cancer (21 papers), Pancreatic and Hepatic Oncology Research (13 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Cancer Diagnosis and Treatment (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.1k citations), Oncology (3.0k citations), Cancer Research (1.5k citations), Immunology (1.3k citations) and Molecular Biology (2.0k citations). Frede Donskov has collaborated with scholars based in Denmark, United States and Canada. Frequent co-authors include Hans von der Maase, Toni K. Choueiri, Brian I. Rini, Georg A. Bjarnason, Lori Wood, Daniel Y.C. Heng, Christian Kollmannsberger, Ulka N. Vaishampayan, Sun Young Rha and Niels Marcussen. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, European Urology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.